In March 2022, researchers from the University of Missouri (Department of Neurology), Society for Healthcare Innovation, and University of Pennsylvania (Departments of Neurology and Anesthesiology and Critical Care) discussed the challenges that emerge on ECMO that can jeopardize antimicrobial therapy success. The complete manuscript by Francisco Gomez, Jesyree Veita, and Krzysztof Laudankski can be found…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest
Sponsored Links
